Biphasic Calcium Phosphate Ceramics for Bone Regeneration and Tissue Engineering Applications by Lobo, Sonja Ellen & Arinzeh, Treena Livingston
Materials 2010, 3, 815-826; doi:10.3390/ma3020815 
 
materials 
ISSN 1996-1944 
www.mdpi.com/journal/materials 
Review 
Biphasic Calcium Phosphate Ceramics for Bone Regeneration 
and Tissue Engineering Applications 
Sonja Ellen Lobo 1,2 and Treena Livingston Arinzeh 2,* 
1 Department of Morphology, Federal University of São Paulo, Rua Botucatu, 740, CEP 04023-900, 
São Paulo, SP, Brazil; E-Mail: sonjael@terra.com.br 
2 Department of Biomedical Engineering, New Jersey Institute of Technology, University Heights; 
614 Fenster Hall, Newark, NJ 07102-1982, USA 
* Author to whom correspondence should be addressed; E-Mail: arinzeh@adm.njit.edu;  
Tel.: +1-973-596-5269. 
Received: 1 December 2009; in revised form: 17 January 2010 / Accepted: 27 January 2010 /  
Published: 29 January 2010 
 
Abstract: Biphasic calcium phosphates (BCP) have been sought after as biomaterials for 
the reconstruction of bone defects in maxillofacial, dental and orthopaedic applications. 
They have demonstrated proven biocompatibility, osteoconductivity, safety and 
predictability in in vitro, in vivo and clinical models. More recently, in vitro and in vivo 
studies have shown that BCP can be osteoinductive. In the field of tissue engineering, they 
represent promising scaffolds capable of carrying and modulating the behavior of stem 
cells. This review article will highlight the latest advancements in the use of BCP and the 
characteristics that create a unique microenvironment that favors bone regeneration. 
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1. Introduction 
Calcium phosphate ceramics have been widely applied as bone substitutes, coatings, cements, drug 
delivery systems and tissue engineering scaffolds due to their resemblance to the mineral portion of the 
bone tissue, relative ease in processing and good cell attachment [1–4]. Its biocompatibility, safety, 
predictability, unlimited availability, lower morbidity for the patient and cost effectiveness represent 
important advantages over autografts and allografts [3,5] and make them a good choice for 
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reconstructive surgery, orthopaedics, dentistry, maxillo and craniofacial surgeries, spinal arthrodesis 
and neurosurgery [3,5–13]. 
Over the years, several modifications on parameters such as sintering temperature, pH and purity of 
the starting products have given rise to calcium phosphates with distinct chemical and physical 
characteristics such as specific surface areas, surface energy, surface charge, roughness and porosity 
[1,3,11,14,15]. Macropores (diameter > 100 μm) and micropores (diameter < 10 μm) can be created in 
bioceramics with the use of porogens/pore-formers and heat treatment [14]. As a consequence, it is 
possible to have a biomaterial that improves the adhesion, proliferation and differentiation of cells, 
which leads to better osteoconductivity, bioactivity and mechanical properties with less brittleness 
[11,16–17]. Although studies demonstrate that some bioceramics have osteoinductive properties, the 
cellular and molecular mechanisms that explain such a process are not completely understood. A few 
theories have considered the physicochemical and structural characteristics of the bioceramic. It has 
been described that a high specific surface area, which can be achieved by increasing the number of 
micropores, is essential for osteoinduction [15,16,18–21]. The presence of concavities, which are 
present at the walls of macropores, has also been considered a key point, for they resemble the 
geometric-dependent event of bone formation [22,23]. Furthermore, the dissolution of the surface 
causes a supersaturation of calcium and phosphate ions, which leads to their reprecipitation and the 
formation of a biological apatite layer [14,16,18,24–26]. This property allows bone-bonding with the 
bioceramic and influences its osteoinduction potential.  
Among the calcium phosphate ceramics, the biphasic calcium phosphates (BCP), which are 
composed of different concentrations of the stable phase, hydroxyapatite (HA), and the more soluble 
phase, usually composed of β-tricalcium phosphate (β-TCP), have presented significant advantages 
over other calcium phosphate ceramics due to their controlled bioactivity and balance between 
resorption/solubilization which guarantees the stability of the biomaterial while promoting bone 
ingrowth [27,28]. Depending upon the concentration of the more stable and soluble phases, it is 
possible to obtain a ceramic that can be applied to large bone defects, in load bearing areas, and as 
customized pieces which will maintain their shape over long periods of time [8,28,29]. 
The nature, timing and progression of bone formation is dependent upon the chemistry and physical 
properties of the bioceramic [1,11]. This review paper describes the physicochemical characteristics of 
BCP that create a unique microenvironment for bone formation and their use as a promising tissue 
engineering scaffold for bone regeneration. 
2. Physicochemical Properties of BCP that Influence Bone Formation 
The type of biological response by the host is critical for bone formation on a bioceramic surface 
and this response is dependent upon the ceramic’s chemical composition and physical structure. A 
bioceramic can be classified according to the type of interface formed between the bioceramic and the 
host tissue. A bioceramic can be classified as inert (where there is a minor fibrous reaction by the host 
on the surface of the biomaterial) and bioactive (where there is a direct biochemical and biological 
bond at the interface with the adjacent bone tissue, via the formation of an apatite layer at the surface 
of the biomaterial). This interface influences the rate and type of bone formation and the stability and 
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Bone formation within a ceramic is a multifactor process that is regulated by several aspects such as 
chemical composition, resorption and dissolution rates, physical structure (e.g., geometry of the pores, 
porosity as well as surface topography) and implantation site. The chemical composition of a 
bioceramic influences the rate of solubilization/resorption as well as its bioactivity. For instance, while 
HA is slowly resorbed and/or solubilized, calcium sulphate, α-TCP and β-TCP undergoes a much 
faster process of resorption. In addition, the rate of resorption can be manipulated by ionic 
substitutions of some salts. The two most described examples are the carbonate and the silicate-
substitute calcium phosphates (Si-CaP) that can present an increased rate of resorption when compared 
to the stoichiometric HA [11,33,34]. A completely resorbable ceramic has been the goal of several 
studies; however, a high rate of resorption or solubilization can interfere with bone formation as the 
biomaterial may degrade faster than the rate of bone formation. This phenomena leads to a change in 
the bioceramic’s physical structure, i.e., loss of the concavity in the macropore and the mechanical 
stability of the surface, which will interfere with cell attachment [16,35]. Moreover, the release of high 
concentrations of calcium to the microenvironment results in a change of the pH, promotes a mild 
inflammatory response and favors fibrous tissue formation [11,36]. Furthermore, higher calcium ion 
levels have been shown to effect osteoclastic activity, varying from its inhibition to its stimulation or 
no effects [37,38]. Consequently, a ceramic with a lower resorption rate is stable for enough period of 
time to allow for the formation of new bone by the host tissue [8]. In addition, the release of controlled 
levels of calcium ions over time favors the formation of an apatite layer, which is necessary for the 
bioactivity displayed in HA/β-TCP ceramics [15,25,28]. This bioactivity can be responsible for the 
ceramic’s osteoconductivity and/or osteoinductivity. In osteoconduction, the biomaterial surface 
supports the growth of mature osteoblasts and direct apposition of bone onto its surface while in 
osteoinduction, the biomaterial favors the recruitment of immature or undifferentiated cells and 
stimulates their differentiation towards the osteoblastic lineage and as a consequence, osteogenesis will 
be stimulated [11,39]. 
The advantages and disadvantages of a bioceramic with high and low resorption or dissolution rates 
have been widely discussed. The resorption process refers to the cell-mediated mechanism while the 
dissolution refers to the chemical process that results from the reaction with the surrounding body 
fluids [1,11,19]. It is important to highlight that nanoparticles (0.1–100 nm) can undergo a process of 
phagocytosis/endocytosis and not dissolution or resorption [11,40]. Nanoparticles of distinct chemical 
compositions can enter the cells through gap junctions or hemichannels and can result in DNA 
damage, alteration of the cell shape and size and cell death [40–43]. Hydroxyapatite nanoparticles have 
been studied as a potential therapy for the suppression and apoptosis of osteosarcoma cells, where 
larger-sized particles appear to be more effective than the smaller ones [43]. The particle size has also 
been related to the modulation of the inflammatory process: the smaller the particle, the higher the 
inflammatory process [44] and can also interfere in the in vitro differentiation of stem cells [45]. 
However, this characteristic should not be confused with nanostructured ceramics in which the surface 
texture improves the attachment and differentiation of osteoprogenitor cells and favors protein 
adsorption due to its increased surface energy [12,46] (Figure 2). 
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Figure 2. SEM image of human mesenchymal stem cells seeded onto a nanostructured 
BCP (Osteosynt ®). 
 
 
The physical structure of bioceramics is represented by the surface topography and by the pore 
structure. Studies have shown that a concave surface favors cell adhesion and proliferation in 
comparison to a convex surface and is responsible for the beginning of the bone formation process 
[22,23,47]. The presence of a macroporous structure favors cell ingrowth and blood vessel invasion 
while the microporosity allows the penetration of body fluids into the implant and increases its 
bioactivity. Consequently, microporosity can also be a strategy to manipulate the resorption and 
dissolution rate: the greater the microporosity, the greater the degradation rate [1,11,14,48,49]. 
Microporosity has been described as one of the factors that influence the intrinsic osteoinductivity of 
some calcium phosphate ceramics [15,16,18–21]. Micropores allow for the entrapment and 
concentration of proteins which, in when contact with undifferentiated cells, will induce their 
differentiation [47,50]. 
Therefore, an understanding of the physiochemical characteristics is extremely important when 
choosing a bioceramic, specifically BCP, as it determines the nature, timing and progress of the tissue 
formation. In addition, the type and rate of new bone formation depends on the age, systemic 
condition, metabolism and lifestyle of the patient, the anatomic area that has to be reconstructed, the 
size of the bone defect, the existence or absence of walls that contain the bioceramic and the surgical 
technique [8,10,11,13,46]. Different areas of the human skeleton present distinct functional loads, bone 
density (ratio between the cortical and the medullar zones) and degree of vascularization [46]. This 
can, in turn, influence the rate of degradation of the ceramic and the overall remodeling  
process [32]. 
3. BCP Ceramics in Bone Tissue Engineering 
A biomaterial that is capable of reconstructing small bone defects may not be suitable to regenerate 
large bone defects [5], where the current approach includes different types of bone grafts [51]. BCP 
ceramics have been considered to be a promising scaffold for use with tissue engineering strategies for 
large bone defect reconstruction. With the aim of improving their osteogenic potential and mechanical 
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properties, such scaffolds have been mixed with autografts, fibrin, platelet concentrate, several  
growth factors, cytokines and more recently with expanded cells isolated from several tissues 
[6,9,17,46,52–55].  
Autologous and allogeneics stem cells have been isolated from different tissues; however 
mesenchymal stem cells (MSC) from the bone marrow are the most studied (Figure 3). Whole bone 
marrow in combination with a scaffold was one of the first strategies described to improve the 
osteogenic potential of synthetic scaffolds [3]. In subsequent studies, MSC isolated from the bone 
marrow, which is the osteogenic cell population within the bone marrow, were used in combination 
with scaffolds to treat bone defects [56]. MSC were expanded in culture and seeded at high densities 
onto large, porous blocks of BCP. Critically-sized segmental defects in various animal species have 
been treated with this approach and have formed functional bone tissue in vivo. These constructs have 
been shown to simulate the events of bone formation observed with autologous bone grafts in long 
bone defects [51].  
 
Figure 3. SEM images of the adhesion and proliferation of human mesenchymal stem cells 
seeded onto a nanostructured BCP ceramic (Osteosynt ®), in the granular form 
corresponding to 40–60 mesh (approx. 250 to 420 μm). (a) day 1; (b) day 7; (c) day 14. 
   
(a)    (b)     (c) 
 
Superior bone formation has also been demonstrated in ectopic studies of cells seeded onto calcium 
phosphate scaffolds in comparison with autograft, allograft or cell-seeded allografts [57]. It has been 
shown in ectopic sites that the ratio of the HA/β-TCP in the BCP can influence the rate of MSC 
induced bone formation, where an optimal balance between the more stable and soluble phases must 
be achieved in order to promote bone tissue formation [54]. 20/80 HA/β-TCP (20 wt % HA: 80 wt % 
β-TCP) scaffolds seeded with human MSC have been shown to have a higher rate of bone formation 
over other HA/β-TCP ratios, 100 HA (100% HA) or 100 β-TCP (100% β-TCP) (Figure 4). More 
recently, MSC have been cultured for a period of time on BCP in order to promote the formation of a 
bone-like tissue layer on the implant, prior to its implantation [3]. This technique requires, however, 
more time for preparation, which can be inconvenient for those patients that need a graft  
immediately [3]. 
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bone formation by the host [60]. Consequently, the requirements for the use of a biomaterial, such as a 
BCP, alone versus in combination with tissue engineering approaches must be defined based on the 
size and type of the defect. 
4. Conclusions 
BCP ceramics are shown to be biocompatible, bioactive, osteoconductive, safe, predictable and 
capable of carrying and inducing the differentiation of stem cells. These characteristics associated with 
the cost, effectiveness, unlimited supply and absence of disease transmission make them a viable 
alternative to autografts, allografts and others implants. 
The ease of tailoring their chemistry, size and shape make them a versatile matrix for the 
development of strategies to engineer bone formation. BCP ceramics vary according to their chemical 
composition and physical structures, which in conjunction with the implantation site, form (granules, 
blocks and customized pieces) and the intrinsic conditions of the patient, can give rise to different rates 
and patterns of bone formation. The knowledge of such parameters is essential in choosing a BCP for a 
specific application. 
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